Myelodysplastic_Syndrome_Molecular_and_Cytogenetic_Features
The lesson teaches the following:
Molecular and Cytogenetic Features of MDS, Mutations in Genes Responsible for Cell Proliferation, Oncogenes: Tyrosine Kinases
Oncogenes: Tyrosine Kinases
Oncogenes: Tyrosine Kinases
Gleevec Prescribing Information Highlights. Page 1.
http://www.medterms.com/script/main/art.asp?articlekey=4870
R.A. Weinberg. The Rational Treatment of Cancer. From The Biology of Cancer. Garland Science, Taylor & Francis Group, New York, N.Y., 2007. Chapter 16, Page 759.
http://mpdfoundation.org/gleevec.htm
H.J. Olney and M.M. Le Beau. Cytogenetic Abnormalities in Myelodysplastic Syndromes. From the Myelodysplastic Syndromes. Clinical and Biological Advances. Edited by P.L. Greenberg. Cambridge University Press, Cambridge, UK. 2006. (Chapter 4, Pp. 115 and 116).
R.M. Hutchinson, J.H. Pringle, S.C. Knight, I. Lauder, A. Potter, C. Jagger. Onocgene Expression in Primary Myelodysplasia: Correlation with Hematological, Karyotypic, and Clinical Progression. J. Clin. Pathol. 45:339-343, 1992. Pg. 341.